Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$646M |
| 2 |
Tesla
TSLA
|
+$572M |
| 3 |
Broadcom
AVGO
|
+$521M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$478M |
| 5 |
lululemon athletica
LULU
|
+$400M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$861M |
| 3 |
Palantir
PLTR
|
+$730M |
| 4 |
iShares Bitcoin Trust
IBIT
|
+$576M |
| 5 |
NVIDIA
NVDA
|
+$443M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 94.35% |
| 2 | Technology | 1.74% |
| 3 | Consumer Discretionary | 0.9% |
| 4 | Financials | 0.71% |
| 5 | Communication Services | 0.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11451
Monte Rosa Therapeutics
GLUE
$1.14B
| $120K | ﹤0.01% |
16,186
-43,164
| -73% | -$229K |
|
11452
PUT
Arbutus Biopharma
ABUS
$1B
| $120K | ﹤0.01% |
26,400
+7,400
| +39% | +$27.2K |
|
11453
Inovio Pharmaceuticals
INO
$133M
| $120K | ﹤0.01% |
51,182
-100,085
| -66% | -$192K |
|
|
TE
11454
CALL
T1 Energy
TE
$1.41B
| $120K | ﹤0.01% |
54,900
-5,100
| -9% | -$8.13K |
|
11455
PUT
Xeris Biopharma Holdings
XERS
$1.55B
| $120K | ﹤0.01% |
14,700
+3,400
| +30% | +$22.6K |
|
11456
Cue Biopharma
CUE
$203M
| $120K | ﹤0.01% |
5,549
+408
| +8% | +$9.57K |
|
|
YSG
11457
PUT
Yatsen Holding
YSG
$285M
| $120K | ﹤0.01% |
13,200
-3,700
| -22% | -$35.2K |
|
11458
PUT
Cemex
CX
$15.7B
| $120K | ﹤0.01% |
13,300
-2,200
| -14% | -$18.8K |
|
11459
CALL
Bioventus
BVS
$945M
| $119K | ﹤0.01% |
17,800
-29,400
| -62% | -$204K |
|
|
ADVM
11460
DELISTED
Adverum Biotechnologies
ADVM
| $119K | ﹤0.01% |
26,255
-32,956
| -56% | -$97.2K |
|
|
CAN
11461
CALL
Canaan Creative
CAN
$283M
| $118K | ﹤0.01% |
134,600
-145,900
| -52% | -$111K |
|
|
RPC
11462
Ridgepost Capital
RPC
$955M
| $118K | ﹤0.01% |
10,866
-61,425
| -85% | -$730K |
|
|
SWZ
11463
Swiss Helvetia Fund
SWZ
$77.8M
| $117K | ﹤0.01% |
19,315
+9,126
| +90% | +$56.1K |
|
|
MCR
11464
DELISTED
MFS Charter Income Trust
MCR
| $117K | ﹤0.01% |
+18,249
| New | +$116K |
|
|
NOM
11465
DELISTED
Nuveen Missouri Quality Municipal Income Fund
NOM
| $117K | ﹤0.01% |
+10,645
| New | +$116K |
|
|
SANG
11466
Sangoma Technologies
SANG
$130M
| $117K | ﹤0.01% |
23,689
+12,352
| +109% | +$70.4K |
|
|
AWF
11467
AllianceBernstein Global High Income Fund
AWF
$876M
| $116K | ﹤0.01% |
10,381
-37,292
| -78% | -$417K |
|
11468
PUT
AngioDynamics
ANGO
$655M
| $116K | ﹤0.01% |
+10,400
| New | +$100K |
|
11469
PUT
Lifestance Health
LFST
$4.7B
| $116K | ﹤0.01% |
21,100
+7,300
| +53% | +$35.8K |
|
|
FTW
11470
Presidio Production Co
FTW
$353M
| $116K | ﹤0.01% |
+11,171
| New | +$116K |
|
11471
CALL
Kura Oncology
KURA
$1.13B
| $116K | ﹤0.01% |
13,100
-9,600
| -42% | -$68.4K |
|
11472
Comtech Telecommunications
CMTL
$50.9M
| $116K | ﹤0.01% |
44,786
+23,738
| +113% | +$54.2K |
|
|
BDN
11473
CALL
Brandywine Realty Trust
BDN
$527M
| $116K | ﹤0.01% |
27,700
+12,300
| +80% | +$51.7K |
|
|
CNH
11474
PUT
CNH Industrial
CNH
$18.8B
| $115K | ﹤0.01% |
10,600
-222,400
| -95% | -$2.72M |
|
11475
Invesco Municipal Income Opportunities Trust
OIA
$290M
| $115K | ﹤0.01% |
+19,026
| New | +$110K |
|
Similar funds
Jeff Yass's Q3 2025 Portfolio in Review
As of Q3 2025, Jeff Yass held 14,336 positions worth $875B, up 22% from $720B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jeff Yass's Q3 2025 filing shows 1,794 new, 5,240 increased, 5,148 reduced and 2,105 closed positions. Its largest new stake was BitMine Immersion Technologies: 7,689,603 shares worth $399M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 94% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q3 2025 buy was BitMine Immersion Technologies: 7,689,603 shares worth $399M.
- Jeff Yass added most to Meta Platforms (Facebook) in Q3 2025, an estimated $646M increase.
- Jeff Yass's biggest Q3 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
- Jeff Yass fully exited iShares Core MSCI Total International Stock ETF in Q3 2025, selling an estimated $123M.
- Jeff Yass's ten largest holdings make up 24% of its $875B portfolio in Q3 2025.
- Jeff Yass opened 1,794 new positions and closed 2,105 in Q3 2025.
- Jeff Yass's portfolio value rose 22% quarter-over-quarter to $875B.
Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.